Beta Bionics, Inc. (BBNX) — 10-Q Filings
All 10-Q filings from Beta Bionics, Inc.. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
Beta Bionics Sales Surge 63%, But Losses Widen Amid High Spend
— Oct 28, 2025 Risk: high
Beta Bionics, Inc. (BBNX) reported a significant increase in net sales for the three and nine months ended September 30, 2025. Net sales for the three months ro -
Beta Bionics' Losses Widen to $40.2M Despite 35% Revenue Jump
— Jul 29, 2025 Risk: high
Beta Bionics, Inc. (BBNX) reported a net loss of $40.2 million for the six months ended June 30, 2025, a significant increase from the $28.5 million net loss fo -
Beta Bionics Files Q1 2025 10-Q, Details Preferred Stock
— May 6, 2025 Risk: medium
Beta Bionics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, focused on surgical and medical instruments, reported financial data for th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX